Open AccessSustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis
Author(s) -
Michael Chapman,
Joshua Cirulli,
Sandy McBride
Publication year - 2018
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.23
Subject(s) - apremilast , psoriasis , medicine , plaque psoriasis , dermatology , pediatrics , psoriatic arthritis
not available. Disclosures: Study supported by Celgene. Copyright SKIN 2018